CDH17: Difference between revisions
Jump to navigation
Jump to search
m (Bot: HTTP→HTTPS) |
Matt Pijoan (talk | contribs) m (1 revision imported) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 18: | Line 18: | ||
*{{cite journal | author=Gilston A |title=Reducing the hazard of disconnected tubes. |journal=Anaesthesia |volume=32 |issue= 9 |pages= 922 |year= 1978 |pmid= 603017 |doi=10.1111/j.1365-2044.1977.tb10133.x }} | *{{cite journal | author=Gilston A |title=Reducing the hazard of disconnected tubes. |journal=Anaesthesia |volume=32 |issue= 9 |pages= 922 |year= 1978 |pmid= 603017 |doi=10.1111/j.1365-2044.1977.tb10133.x }} | ||
*{{cite journal | vauthors=Dantzig AH, Hoskins JA, Tabas LB |title=Association of intestinal peptide transport with a protein related to the cadherin superfamily. |journal=Science |volume=264 |issue= 5157 |pages= 430–3 |year= 1994 |pmid= 8153632 |doi=10.1126/science.8153632 |display-authors=etal}} | *{{cite journal | vauthors=Dantzig AH, Hoskins JA, Tabas LB |title=Association of intestinal peptide transport with a protein related to the cadherin superfamily. |journal=Science |volume=264 |issue= 5157 |pages= 430–3 |year= 1994 |pmid= 8153632 |doi=10.1126/science.8153632 |display-authors=etal}} | ||
*{{cite journal | vauthors=Suzuki Y, Tsunoda T, Sese J |title=Identification and characterization of the potential promoter regions of 1031 kinds of human genes. |journal=Genome Res. |volume=11 |issue= 5 |pages= 677–84 |year= 2001 |pmid= 11337467 |doi= 10.1101/gr. | *{{cite journal | vauthors=Suzuki Y, Tsunoda T, Sese J |title=Identification and characterization of the potential promoter regions of 1031 kinds of human genes. |journal=Genome Res. |volume=11 |issue= 5 |pages= 677–84 |year= 2001 |pmid= 11337467 |doi= 10.1101/gr.gr-1640r| pmc=311086 |display-authors=etal}} | ||
*{{cite journal | vauthors=Grötzinger C, Kneifel J, Patschan D |title=LI-cadherin: a marker of gastric metaplasia and neoplasia. |journal=Gut |volume=49 |issue= 1 |pages= 73–81 |year= 2001 |pmid= 11413113 |doi=10.1136/gut.49.1.73 | pmc=1728355 |display-authors=etal}} | *{{cite journal | vauthors=Grötzinger C, Kneifel J, Patschan D |title=LI-cadherin: a marker of gastric metaplasia and neoplasia. |journal=Gut |volume=49 |issue= 1 |pages= 73–81 |year= 2001 |pmid= 11413113 |doi=10.1136/gut.49.1.73 | pmc=1728355 |display-authors=etal}} | ||
*{{cite journal | vauthors=Strausberg RL, Feingold EA, Grouse LH |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |display-authors=etal}} | *{{cite journal | vauthors=Strausberg RL, Feingold EA, Grouse LH |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |display-authors=etal}} | ||
Latest revision as of 08:45, 10 January 2019
| VALUE_ERROR (nil) | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Aliases | |||||||
| External IDs | GeneCards: [1] | ||||||
| Orthologs | |||||||
| Species | Human | Mouse | |||||
| Entrez |
|
| |||||
| Ensembl |
|
| |||||
| UniProt |
|
| |||||
| RefSeq (mRNA) |
|
| |||||
| RefSeq (protein) |
|
| |||||
| Location (UCSC) | n/a | n/a | |||||
| PubMed search | n/a | n/a | |||||
| Wikidata | |||||||
| |||||||
Cadherin-17 is a protein that in humans is encoded by the CDH17 gene.[1][2][3]
This gene is a member of the cadherin superfamily, genes encoding calcium-dependent, membrane-associated glycoproteins. The encoded protein is cadherin-like, consisting of an extracellular region, containing 7 cadherin domains, and a transmembrane region but lacking the conserved cytoplasmic domain. The protein is a component of the gastrointestinal tract and pancreatic ducts, acting as an intestinal proton-dependent peptide transporter in the first step in oral absorption of many medically important peptide-based drugs. The protein may also play a role in the morphological organization of liver and intestine.[3]
References
- ↑ Kremmidiotis G, Baker E, Crawford J, Eyre HJ, Nahmias J, Callen DF (Aug 1998). "Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity". Genomics. 49 (3): 467–71. doi:10.1006/geno.1998.5281. PMID 9615235.
- ↑ Chalmers IJ, Hofler H, Atkinson MJ (Jun 1999). "Mapping of a cadherin gene cluster to a region of chromosome 5 subject to frequent allelic loss in carcinoma". Genomics. 57 (1): 160–3. doi:10.1006/geno.1998.5717. PMID 10191097.
- ↑ 3.0 3.1 "Entrez Gene: CDH17 cadherin 17, LI cadherin (liver-intestine)".
Further reading
- Gessner R, Tauber R (2001). "Intestinal cell adhesion molecules. Liver-intestine cadherin". Ann. N. Y. Acad. Sci. 915: 136–43. doi:10.1111/j.1749-6632.2000.tb05236.x. PMID 11193569.
- Gilston A (1978). "Reducing the hazard of disconnected tubes". Anaesthesia. 32 (9): 922. doi:10.1111/j.1365-2044.1977.tb10133.x. PMID 603017.
- Dantzig AH, Hoskins JA, Tabas LB, et al. (1994). "Association of intestinal peptide transport with a protein related to the cadherin superfamily". Science. 264 (5157): 430–3. doi:10.1126/science.8153632. PMID 8153632.
- Suzuki Y, Tsunoda T, Sese J, et al. (2001). "Identification and characterization of the potential promoter regions of 1031 kinds of human genes". Genome Res. 11 (5): 677–84. doi:10.1101/gr.gr-1640r. PMC 311086. PMID 11337467.
- Grötzinger C, Kneifel J, Patschan D, et al. (2001). "LI-cadherin: a marker of gastric metaplasia and neoplasia". Gut. 49 (1): 73–81. doi:10.1136/gut.49.1.73. PMC 1728355. PMID 11413113.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Takamura M, Sakamoto M, Ino Y, et al. (2003). "Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas". Cancer Sci. 94 (5): 425–30. doi:10.1111/j.1349-7006.2003.tb01459.x. PMID 12824888.
- Wendeler MW, Praus M, Jung R, et al. (2004). "Ksp-cadherin is a functional cell-cell adhesion molecule related to LI-cadherin". Exp. Cell Res. 294 (2): 345–55. doi:10.1016/j.yexcr.2003.11.022. PMID 15023525.
- Ko S, Chu KM, Luk JM, et al. (2004). "Overexpression of LI-cadherin in gastric cancer is associated with lymph node metastasis". Biochem. Biophys. Res. Commun. 319 (2): 562–8. doi:10.1016/j.bbrc.2004.04.197. PMID 15178443.
- Takamura M, Ichida T, Matsuda Y, et al. (2004). "Reduced expression of liver-intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinoma". Cancer Lett. 212 (2): 253–9. doi:10.1016/j.canlet.2004.03.016. PMID 15279905.
- Beausoleil SA, Jedrychowski M, Schwartz D, et al. (2004). "Large-scale characterization of HeLa cell nuclear phosphoproteins". Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. doi:10.1073/pnas.0404720101. PMC 514446. PMID 15302935.
- Wang XQ, Luk JM, Leung PP, et al. (2005). "Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma". Clin. Cancer Res. 11 (2 Pt 1): 483–9. PMID 15701831.
- Wang XQ, Luk JM, Garcia-Barcelo M, et al. (2007). "Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma". Clin. Cancer Res. 12 (17): 5248–52. doi:10.1158/1078-0432.CCR-06-0558. PMID 16951245.
External links
- CDH17 human gene location in the UCSC Genome Browser.
- CDH17 human gene details in the UCSC Genome Browser.
- Human CDH16 genome location and CDH16 gene details page in the UCSC Genome Browser.
 | This article on a gene on human chromosome 8 is a stub. You can help Wikipedia by expanding it. |